Key points are not available for this paper at this time.
Our 24-microRNA predictor improves lung cancer prediction beyond that of known risk factors.
Wozniak et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: